T. Senda et al., EFFECT OF SA4503, A NOVEL SIGMA(1) RECEPTOR AGONIST, AGAINST GLUTAMATE NEUROTOXICITY IN CULTURED RAT RETINAL NEURONS, European journal of pharmacology, 342(1), 1998, pp. 105-111
We examined the effects of sigma(1) receptor agonists against glutamat
e-induced neurotoxicity in cultured retinal neurons. Primary cultures
obtained from fetal rat retinas (16-19 d gestation) were used. The neu
rotoxic effect of glutamate was quantitatively assessed using the tryp
an blue exclusion method. A brief exposure of retinal cultures to glut
amate (500 mu M) led to delayed neuronal cell death. The glutamate-ind
uced neurotoxicity was inhibited by 11-dihydro-5H-dibenzo-[a,b]-cycloh
epten-5,10-imine hydrogen maleate (MK-801). The sigma(1) receptor agon
ists, -dimethoxyphenethyl)-4-(3-phenylpropyl)-piperazine dihydrochlori
de (SA4503) and(+)-pentazocine at a concentration range of 0.1 similar
to 100 mu M reduced the glutamate-induced neurotoxicity in a dose-dep
endent manner. In addition, the neuroprotective effects of both SA4503
and (+)-pentazocine were antagonized by co-treatment with N, l-2-[4-m
ethoxy-3-(2-phenylethoxy)phenyl]ethylamine monohydrochloride (NE-100),
a putative sigma(1) receptor antagonist. These findings suggest that
sigma(1) receptor agonists protect retinal cells against glutamate-ind
uced neurotoxicity. (C) 1998 Elsevier Science B.V.